FORM 1 - Individual Substantial Shareholder Notice
 
Form Serial Number: IS20260629E00115
1. Date of relevant event: 24/06/2026
(dd/mm/yyyy)
2. Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 07630
4. Name of listed corporation: IMPACT Therapeutics, Inc - B - H Shares 
5. Class of shares: H Shares 
6. Number of issued shares in class: 282,461,530
7. Name of substantial shareholder (English) as printed on HKID Card/Passport:
(Surname) Shi
(Other names) Yi
10. Name of substantial shareholder (Chinese): 施毅 
11. Chinese Character Code as printed on HKID Card:
 
14. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Nature of consideration
Long position 
1101The percentage level of your interest in the shares has increased because:
you purchased the shares
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 
20,000  HKD  35.9388  35.9388   
 
Short position 
 
 
 
           
15. Total shares immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position39,531,46014.00
 
16. Total shares immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position39,551,46014.00
 
17. Capacity in which interests disclosed in Box 16 are held:
Capacity codeNumber of shares
2201Interest of corporation controlled by you
Long position39,551,460
 
18. Further information in respect of derivative interests:
Derivatives codeNumber of shares
  
 
19. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
20. Further information in relation to interests of corporations controlled by substantial shareholder:
Name of controlled corporationAddress and place of incorporationName of controlling shareholder% controlDirect interest (Y/N)Number of shares
LAV Corporate GP, Ltd.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)Shi Yi100.00N
Long position8,789,975
Lilly Asia Ventures Fund GP, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV Corporate GP, Ltd.100.00N
Long position8,789,975
Lilly Asia Ventures Fund II, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)Lilly Asia Ventures Fund GP, L.P.100.00N
Long position8,789,975
LAV Innovation (Hong Kong) Co., Limited6/F, CNT Commercial Building, No. 302 Queen's Road Central, Hong Kong (Hong Kong)Lilly Asia Ventures Fund II, L.P.100.00Y
Long position8,789,975
LAV Corporate IV GP, Ltd.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)Shi Yi100.00N
Long position14,220,861
LAV GP IV, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV Corporate IV GP, Ltd.100.00N
Long position14,220,861
LAV Biosciences Fund IV, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV GP IV, L.P.100.00N
Long position14,220,861
LAV Enterprise Hong Kong Limited6/F, CNT Commercial Building, No. 302 Queen's Road Central, Hong Kong (Hong Kong)LAV Biosciences Fund IV, L.P.100.00Y
Long position14,220,861
LAV Corporate V GP, Ltd.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)Shi Yi100.00N
Long position6,846,397
LAV GP V, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV Corporate V GP, Ltd.100.00N
Long position6,846,397
LAV Biosciences Fund V, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV GP V, L.P.100.00N
Long position6,846,397
LAV Integra LimitedTrinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)LAV Biosciences Fund V, L.P.100.00Y
Long position6,846,397
LAV Corporate VI GP, Ltd.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)Shi Yi100.00N
Long position4,767,114
LAV GP VI, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV Corporate VI GP, Ltd.100.00N
Long position4,767,114
LAV Fund VI, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV GP VI, L.P.100.00N
Long position4,767,114
LAV Impetus LimitedTrinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)LAV Fund VI, L.P.50.00Y
Long position3,362,914
LAV Impetus LimitedTrinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)LAV Fund VI Opportunities, L.P50.00Y
Long position3,362,913
LAV Star LimitedTrinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)LAV Fund VI, L.P.100.00Y
Long position1,404,200
LAV Corporate VI GP Opportunities, Ltd.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)Shi Yi100.00N
Long position4,377,113
LAV GP VI Opportunities, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV Corporate VI GP Opportunities, Ltd.100.00N
Long position4,377,113
LAV Fund VI Opportunities, L.P.190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV GP VI Opportunities, L.P.100.00N
Long position4,377,113
LAV Star Opportunities LimitedTrinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands (British Virgin Islands)LAV Fund VI Opportunities, L.P.100.00Y
Long position1,014,200
LAV Asset Management (Hong Kong) Limited22nd Floor, Tai Yau Building, 181 Johnston Road, Wan Chai (Hong Kong)Shi Yi100.00Y
Long position39,551,460
LAV Public Equity Master Fund190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands)LAV Asset Management (Hong Kong) Limited100.00Y
Long position550,000
 
21. Further information in relation to interests held by substantial shareholder jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
22. Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust:
Names of trustAddressStatus codeNumber of shares
  
 
23. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
 
24. Supplementary information: LAV Star Opportunities Limited purchased 20,000 shares of IMPACT Therapeutics, Inc - B - H Shares, with trade date on June 24, 2026 and settlement date on June 26, 2026. The ownership percentage immediately before the relevant event was 13.9953% (rounded to 14.00% in 2 decimal places), and the ownership percentage immediately after the relevant event was 14.0024% (rounded to 14.00% in 2 decimal places).
25. Log/Serial Number of the previous form:
26. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 1: 29/06/2026
(dd/mm/yyyy)